Search Results - "Cameselle García, Soledad"
-
1
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
Published in PloS one (01-01-2022)“…The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line treatment…”
Get full text
Journal Article -
2
PD‑L1 expression and immune cells in anaplastic carcinoma and poorly differentiated carcinoma of the human thyroid gland: A retrospective study
Published in Oncology letters (01-07-2021)“…Anaplastic thyroid carcinoma (ATC) and poorly differentiated thyroid carcinoma (PDTC) have limited treatment options, and immune profiling may help select…”
Get full text
Journal Article -
3
Sustained Stable Disease with Capecitabine plus Bevacizumab in Metastatic Appendiceal Adenocarcinoma: A Case Report
Published in Case reports in oncology (01-01-2020)“…In a patient who had been diagnosed in 2006 with appendiceal adenocarcinoma with peritoneal metastases after an incomplete surgery, palliative chemotherapy was…”
Get full text
Journal Article -
4
Cribriform morular thyroid carcinoma: Clinicopathological and molecular basis for both a preventive and therapeutic approach for a rare tumor (Review)
Published in Oncology reports (01-09-2024)“…Cribriform morular thyroid carcinoma (CMTC) has been included within the group of thyroid tumors of uncertain histogenesis in the recent World Health…”
Get more information
Journal Article -
5
Dynamic nature of BRAF or KRAS p.G12C mutations in second-line therapy for advanced colorectal cancer patients: do early and late effects exist?
Published in British journal of cancer (23-03-2024)“…Introduction The mitogen-activated protein kinase (MAPK) signalling network aberrations in metastatic colorectal cancer (mCRC) generate intrinsic dynamic…”
Get full text
Journal Article -
6
Susceptibility Genes and Chromosomal Regions Associated With Non-Syndromic Familial Non-Medullary Thyroid Carcinoma: Some Pathogenetic and Diagnostic Keys
Published in Frontiers in endocrinology (Lausanne) (28-02-2022)“…Thyroid cancer is the malignant tumor that is increasing most rapidly in the world, mainly at the expense of sporadic papillary thyroid carcinoma. The somatic…”
Get full text
Journal Article -
7
Cribriform morular thyroid carcinoma: a case report with pathological, immunohistochemical, and molecular findings suggesting an origin from follicular cells (or their endodermal precursors)
Published in Virchows Archiv : an international journal of pathology (01-03-2023)“…Cribriform morular thyroid carcinoma (CMTC) is a rare malignant thyroid tumor with a peculiar growth pattern secondary to permanent activation of the…”
Get full text
Journal Article -
8
Is the transverse colon the new right?—similarities in EGFR drug response and prognosis
Published in Journal of gastrointestinal oncology (31-10-2024)Get full text
Journal Article -
9
Rechallenge with Anti-EGFR Treatment in RAS/BRAF wt Metastatic Colorectal Cancer (mCRC) in Real Clinical Practice: Experience of the GITuD Group
Published in Targeted oncology (01-07-2024)“…Background There are few third- and fourth-line therapeutic options for metastatic colorectal cancer (mCRC). In RAS/BRAF wild-type (wt) mCRC previously treated…”
Get full text
Journal Article -
10
Neoplasia papilar mucinosa intraductal (NPMI) de conducto pancreático principal
Published in Galicia-clinica (2018)“…Intraductal papillary mucinous neoplasm (IPMN) is an epithelial tumor of mucin-producing cells arising in the main pancreatic duct or its branches. Many cases…”
Get full text
Journal Article -
11
Primary malignant melanoma of the biliary tract: A case report and literature review
Published in World journal of clinical cases (26-08-2019)Get full text
Journal Article -
12
Efficacy and safety of FOLFIRI/aflibercept after failure of an oxaliplatin-based regimen
Published in PloS one (03-06-2022)“…Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line…”
Get full text
Journal Article -
13
Efficacy and safety of FOLFIRI/aflibercept
Published in PloS one (03-06-2022)“…Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line…”
Get full text
Journal Article -
14
Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen
Published in PloS one (01-01-2022)“…Background The VELOUR study showed the benefit of FOLFIRI-Aflibercept (FA) versus FOLFIRI in patients with metastatic colorectal cancer (mCRC) in second-line…”
Get full text
Journal Article -
15
Third and successive–lines of chemotherapy in NSCLC patients without therapeutic targets: Experience of the Grupo Gallego de Cáncer de Pulmón
Published in Journal of clinical oncology (20-05-2019)“…Abstract only e20579 Background: The current treatment of advanced non-small cell lung cancer (NSCLC) is conditioned by the presence of molecular and…”
Get full text
Journal Article -
16
-
17
Primary malignant melanoma of the biliary tract: A case report and literature review
Published in World journal of clinical cases (26-08-2019)“…BACKGROUNDPrimary malignant melanoma of the biliary tract (MBT) is a rare condition whose diagnosis requires excluding a primary origin in another location…”
Get full text
Report